NEW APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
Abstract
Oncological diseases are the second leading cause of deaths. Immune system disorders and enzymatic imbalances undoubtedly play a role in the development of tumors. Despite the multifactorial nature of oncological pathology development, endogenous lysozyme deficiency is an important condition of a disease nosogenesis. The article provides a theoretical and experimental validation for the use of lysozyme and antioxidant agents as an alternative therapy for oncological diseases.
Key words: oncological diseases, lycozyme, isoantigens, muramine, free radicals.
(Pediatric Pharmacology. – 2010; 7(4):37-39)
About the Authors
V.G. DorofeichukRussian Federation
P.P. Potekhin
Russian Federation
S.A. Sher
Russian Federation
Review
For citations:
Dorofeichuk V., Potekhin P., Sher S. NEW APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES. Pediatric pharmacology. 2010;7(4):37-39.
Email this article 